Scientists are using AI to speed up drug repurposing, expanding the treatment possibilities for people with rare diseases and few options
Joseph Coates, left, owes his life to an A.I. model developed by Dr. David Fajgenbaum and the rest of his team.Hannah Yoon for The New York Times Bluesky: @rjcc , @karissabe , @nochoicebutaction , and...
Adept, which aims to build AI systems that can understand and automate any software process, emerges from stealth with $65M led by Greylock and Addition
Adept is an ML research and product lab building general intelligence … Ben G / Ben Goldhaber's Newsletter : April 2022 BenGoldhaber(.com) Newsletter Tweets: Scott Belsky / @scottbelsky : developing A...
OpenAI, a new nonprofit for AI research, gets $1B commitment from SV leaders including Reid Hoffman, Elon Musk, Peter Thiel, also AWS, Infosys, YC Research
Introducing OpenAI — OpenAI is a non-profit artificial intelligence research company. Our goal is to advance digital intelligence …
OpenAI, a new nonprofit for AI research, gets $1B commitment from SV leaders including Reid Hoffman, Elon Musk, Peter Thiel, also AWS, Infosys, YC Research
Introducing OpenAI — OpenAI is a non-profit artificial intelligence research company. Our goal is to advance digital intelligence …